Merck (MRK) Asset Utilization Ratio (2009 - 2026)

Merck (MRK) reported Asset Utilization Ratio of 0.5 for Q1 2026, down 10.02% year-over-year from 0.55 in Q1 2025, and up 1.49% quarter-over-quarter from 0.49 in Q4 2025.

Merck (MRK) Asset Utilization Ratio (2009 - 2026) Analysis & Trends

Merck (MRK) has 18 years of Asset Utilization Ratio data on file, last reported at 0.5 in Q1 2026.

  • Asset Utilization Ratio for Q1 2026 came in at 0.5, down 10.02% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.5 (down 10.02% YoY), and the FY2025 annual result was 0.51, down 10.73% from the prior year.
  • Asset Utilization Ratio climbed to 0.5 in Q1 2026 per MRK's latest filing, from 0.49 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.58 in Q1 2024 and troughed at 0.49 in Q4 2025.
  • A 5-year average of 0.54 and a median of 0.55 in 2022 frame the typical range for Asset Utilization Ratio.
  • The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio gained 12.12% in 2022, then declined 10.77% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.55 in 2022, then increased by 2.75% to 0.56 in 2023, then fell by 2.92% to 0.55 in 2024, then decreased by 10.77% to 0.49 in 2025, then increased by 1.49% to 0.5 in 2026.
  • Business Quant data shows MRK's Asset Utilization Ratio at 0.5 in Q1 2026, 0.49 in Q4 2025, and 0.52 in Q3 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 0.53
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 0.63
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 0.48
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 0.46
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 0.50
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 0.41
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 0.52
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 0.12
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 0.55
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 0.50
Dec 31, 2025 0.49
Sep 30, 2025 0.52
Jun 30, 2025 0.55
Mar 31, 2025 0.55
Dec 31, 2024 0.55
Sep 30, 2024 0.55
Jun 30, 2024 0.57
Mar 31, 2024 0.58
Dec 31, 2023 0.56
Sep 30, 2023 0.56
Jun 30, 2023 0.55
Mar 31, 2023 0.53
Dec 31, 2022 0.55
Sep 30, 2022 0.55
Jun 30, 2022 0.53
Mar 31, 2022 0.51
Dec 31, 2021 0.49
Sep 30, 2021 0.50
Jun 30, 2021 0.48